BioSpace News Archive

Neural Therapeutics Inc. (“Neural” or the “Company”) is pleased to announce that after nearly 11 months of a rigorous review process, the Company has received a key permission from Servicio Nacional Forestal y de Fauna Silvestre

Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the second quarter and first half of 2023 after market close on August 10, 2023.

IgA nephropathy is an autoimmune glomerular disease and leading cause of chronic kidney disease.

icotec, a leading medical device manufacturer specializing in BlackArmor® Carbon/PEEK spinal implants, is pleased to announce the receipt of FDA 510(k) clearance for its VADER® Pedicle System Navigated Instruments.

The Committee to Restore Nymox Shareholder Value, LLC, with a goal to recover shareholder value in NYMOX PHARMACEUTICAL CORP, challenges the Company to publish a rarely issued Refusal to File Letter from the US Food and Drug Administration in the pursuit of full transparency and in the interests of all shareholders.

Talis Biomedical Corporation (Nasdaq: TLIS) today announced new data supporting the development of its planned CT/NG/TV and vaginal infection panels.

Horizon Therapeutics plc announced the 50 awardees from around the world selected to receive the 2023 #RAREis™ Global Advocate Grant.

Harmony Biosciences Holdings, Inc. today announced it has entered into a new $185 million senior secured term loan facility with a bank syndicate.

Biora Therapeutics, Inc. today announced progress with its latest clinical device performance study, evaluating the device function and safety of its NaviCap™ targeted oral delivery platform.

Ayala Pharmaceuticals, Inc. and Biosight Ltd. today announced they have entered into a definitive merger agreement pursuant to which Ayala will combine with Biosight in an all-stock transaction.